Skip to main content
Journal of Applied Clinical Medical Physics logoLink to Journal of Applied Clinical Medical Physics
. 2024 May 13;25(7):e14386. doi: 10.1002/acm2.14386

Optimization of photon counting CT for cardiac imaging in patients with left ventricular assist devices: An in‐depth assessment of metal artifacts

Bente Konst 1,2,3,, Linus Ohlsson 2,4, Lilian Henriksson 2,5, Mårten Sandstedt 2,5, Anders Persson 2,5, Tino Ebbers 1,2
PMCID: PMC11244676  PMID: 38739330

Abstract

Purpose

Photon counting CT (PCCT) holds promise for mitigating metal artifacts and can produce virtual mono‐energetic images (VMI), while maintaining temporal resolution, making it a valuable tool for characterizing the heart. This study aimed to evaluate and optimize PCCT for cardiac imaging in patients during left ventricular assistance device (LVAD) therapy by conducting an in‐depth objective assessment of metal artifacts and visual grading.

Methods

Various scan and reconstruction settings were tested on a phantom and further evaluated on a patient acquisition to identify the optimal protocol settings. The phantom comprised an empty thoracic cavity, supplemented with heart and lungs from a cadaveric lamb. The heart was implanted with an LVAD (HeartMate 3) and iodine contrast. Scans were performed on a PCCT (NAEOTOM Alpha, Siemens Healthcare). Metal artifacts were assessed by three objective methods: Hounsfield units (HU)/SD measurements (DiffHU and SDARTIFACT), Fourier analysis (AmplitudeLowFreq), and depicted LVAD volume in the images (BloomVol). Radiologists graded metal artifacts and the diagnostic interpretability in the LVAD lumen, cardiac tissue, lung tissue, and spinal cord using a 5‐point rating scale. Regression and correlation analysis were conducted to determine the assessment method most closely associated with acquisition and reconstruction parameters, as well as the objective method demonstrating the highest correlation with visual grading.

Results

Due to blooming artifacts, the LVAD volume fluctuated between 27.0 and 92.7 cm3. This variance was primarily influenced by kVp, kernel, keV, and iMAR (R = 0.989). Radiologists favored pacemaker iMAR, 3 mm slice thickness, and T3D keV and kernel Bv56f for minimal metal artifacts in cardiac tissue assessment, and 110 keV and Qr40f for lung tissue interpretation. The model adequacy for DiffHU SDARTIFACT, AmplitueLowFreq, and BloomVol was 0.28, 0.76, 0.29, and 0.99 respectively for phantom data, and 0.95, 0.98, 1.00, and 0.99 for in‐vivo data. For in‐vivo data, the correlation between visual grading (VGSUM) and DiffHU SDARTIFACT, AmplitueLowFreq, and BloomVol was −0.16, −0.01, −0.48, and −0.40 respectively.

Conclusion

We found that optimal scan settings for LVAD imaging involved using 120 kVp and IQ level 80. Employing T3D with pacemaker iMAR, the sharpest allowed vascular kernel (Bv56f), and VMI at 110 keV with kernel Qr40 yields images suitable for cardiac imaging during LVAD‐therapy. Volumetric measurements of the LVAD for determination of the extent of blooming artifacts was shown to be the best objective method to assess metal artifacts.

Keywords: heart, left ventricular assistance device, metal artifact, myocardium, photon‐counting computed tomography

1. INTRODUCTION

Heart failure is a global health concern, leading to millions of deaths annually. 1 , 2 In advanced stages, heart transplantation offers the best prognosis, but donor scarcity and contraindications limit this option. 3 As a result, durable mechanical circulatory support (dMCS) has made important strides, mostly due to the technical development within left ventricular assist devices (LVADs). 4 In the realm of LVAD therapy, the HeartMate 3 (HM3) (Abbott Laboratories, Lake Forest, IL), a fully magnetically levitated centrifugal flow pump, has seen increasing prominence in recent years, and its dominance is highlighted in the latest international MCS register reports. 5 Patients suitable for LVAD therapy come with varied pathologies and the patient group demand individualized care and continuous optimization of system settings to prevent complications. 6 While echocardiography is the gold standard to assess cardiac function during LVAD therapy, it faces notable challenges. The metal of the LVAD severely limits the acoustic window resulting in an inability to visualize the entire outflow graft 7 and restricting assessment of thrombosis, bleeding, and infections. 8 Time‐resolved computed tomography (CT) datasets allow the calculation of various functional cardiac parameters including volumes, ejection fraction, myocardial mass, and wall motion. 9 , 10 CT may also offer a valuable alternative to echocardiography for the detection of conditions such as thrombosis, cannula malposition, and bleeding, and its adoption has been on the rise. 11 In energy integrated detector (EID) CT, the presence of metal in the LVAD commonly introduces image artifacts, such as beam hardening, blooming, noise, and scatter, which for instance explains the relatively low sensitivity and high specificity for detection of LVAD thrombus. 12 These artifacts, combined with other prominent non‐optimal conditions in cardiac CT imaging, limit the diagnostic quality and the clinical utility.

Advantages of photon counting CT (PCCT) over EID include decreased electronic noise, improved spectral and spatial resolution, and increased contrast‐to‐noise ratio. 13 LVAD patients often have renal dysfunction before LVAD implantation, 14 hence it is favorable that PCCT allows for reduced iodine contrast media. 15 , 16 PCCT also holds promise for mitigating metal artifacts, particularly in the case of light metals. 17 , 18 PCCT can produce virtual mono‐energetic images (VMI), while maintaining temporal resolution, making it a valuable tool for characterizing the heart and myocardium. 15 , 19 , 20 , 21 , 22

Three strategies to mitigate metal artifacts are: (1) simulation of mono‐energetic energies at high energy, (2) use of raw data with modified iterative reconstruction, (3) application of dedicated Metal Artefact Reduction (MAR) algorithms on projection data. 23 , 24 , 25 , 26

PCCT holds great promise for cardiac imaging in patients during LVAD therapy, and there is a consensus on the utilization of CT for postoperative imaging of LVAD patients. 11 , 27 However, a CT protocol delineating the optimal combination of metal artifact mitigating strategies for EID 11 and PCCT for LVAD imaging is currently lacking. Very few studies describe CT in LVAD, 28 and our study may provide knowledge about LVAD diagnostics with new technology.

This study aimed to evaluate and optimize PCCT for cardiac imaging in patients during LVAD therapy by conducting an in‐depth objective assessment of metal artifacts and visual grading. We assessed the impact of different scan and reconstruction parameter settings on image quality using a phantom. The outcomes of these phantom images guided the development of a CT protocol, which was then applied to an LVAD patient for further evaluation. Additionally, we explored potential correlations between visual grading and objective methods used to assess metal artifacts.

2. MATERIALS AND METHODS

Various scan and reconstruction settings were tested on a phantom and further evaluated in vivo. The phantom consisted of a commercial chest phantom withholding a lamb's heart and lungs, iodine contrast, and an LVAD. PCCT scans of the phantom were performed with various settings, including different kVp, dose levels, image filtration (kernels), slice thicknesses, and MAR presets. We determined the most suitable imaging parameters through a combination of visual grading and objective metal artifact assessment. To evaluate the correlation between metal artifact assessment methods and visual grading, we calculated Spearman's rho. Subsequently, we developed a patient protocol and obtained and evaluated an initial in‐vivo dataset within this study. For a detailed overview of our methodology, please refer to Figure 1, the study's flowchart.

FIGURE 1.

FIGURE 1

Flowchart of the study methodology.

2.1. Phantom and patient

The phantom utilized in this study was based on a commercially available chest phantom, supplemented with additional chest plates (Multipurpose Chest Phantom N1, Lungman, PH‐1; Kyoto‐Kagaku Co., Ltd., Kyoto, Japan). 29 The phantom material of the inner thoracic cavity was replaced by a lamb's heart and lung, in which a real LVAD prototype (HeartMate 3), had been surgically sutured on to the left ventricular apex (see Figure 2). Additionally, the ventricles were filled with iodine contrast and simulated tumors 3.5 and 8 mm in diameter, with distinct nominal Hounsfield units (HU) values, were placed into the thoracic cavity. These tumors were crafted from urethane foam, with a nominal HU value of approximately −630. In contrast, polyurethane, SZ50, and hydroxyapatite displayed nominal HU values of +100.

FIGURE 2.

FIGURE 2

A multipurpose chest phantom N1, “Lungman,” PH‐1; Kyoto‐Kagaku. The lung insert was replaced with lamb heart and lungs with an LVAD. Extra chest plates were added to simulate a standard patient size.

The patient study was performed in agreement with the Declaration of Helsinki and had been approved by the Swedish Ethical Review Authority (Dnr: 2022‐06934‐01). The study participant provided informed written consent prior to participation. The inclusion criteria were patients associated with Linköping University hospital undergoing treatment with HeartMate 3 and aged 18 or older. Exclusion criteria included known iodine contrast allergies, reduced kidney function, pregnancy, newly diagnosed thyroid cancer, untreated hyperthyroidism and myasthenia gravis.

2.2. Image acquisition and reconstruction

Both phantom and patient underwent imaging using a dual‐source PCCT scanner (NAEOTOM Alpha, Siemens Healthcare, Forchheim, Germany). All scans were made using an electrocardiogram (ECG)‐triggered cardiac dual source spiral scan mode which enabled spectral post processing. The general CT scan parameters were set as follows: 0.25 s rotation time, 66 ms temporal resolution, 144 × 0.4 mm collimation, 0.31 pitch factor.

For the phantom scans, a synthetic ECG signal of 60 bpm was used. Automated tube current modulation (CARE Dose4D and CARE keV, Siemens) was employed, and the radiation dose was adjusted by changing the image quality (IQ) level. The kVp values were changed manually and the scans were optimized for vascular examinations. Preliminary phantom tests indicated that settings with 70 kVp did not yield satisfactory image quality. Neither did 90 kVp with an IQ level below 55. Various image reconstructions were made with different kernels, slice thicknesses, and iMAR (iterative metal artifact reconstruction, Siemens) settings. The spectral properties of the PCCT data were utilized to acquire VMI at different keV levels as well as poly‐energetic reconstructions, encompassing photon energies ranging from 20 to 120 keV (T3D). An energy threshold at 20 keV was automatically applied to all reconstructions for removal of electronic noise. Quantum iterative reconstruction (QIR) was set to a strength level of 4 for all images. All included scans and reconstructions are specified in Table 1.

TABLE 1.

Detailed scan and reconstruction parameters for images acquired for both phantom and patient.

Tube Voltage (kVp) Collimation (mm) IQ CTDI Vol (mGy) Recon kernel Slice thickness (mm) VMI (keV) iMAR preset
90 144 × 0.4 80 52.6 Qr40 0.4 110 Pacemaker
120 56.7 T3D Pacemaker
140 58.8
120 144 × 0.4 55 39 Qr40 0.4 110 Pacemaker
120 60 43.3
120 80 56.9
120 100 31.2
140 55 39.6
140 60 53.4
140 80 58.8
120 144 × 0.4 80 56.7 Qr36* 0.4 110 Pacemaker
Qr40*
Qr44*
Bl56*
Bv36*
Bv40*
Bv44*
Bv56*
Qr56 *
120 144 × 0.4 80 56.9 Qr40/4* 0.4 110 None*
Bv56** Pacemaker*
Thoracic Coils*
Hip Implants*
Extremity Implants*
120 144 × 0.4 80 56.9 Qr40 0.4 T3D * Pacemaker
Bv56** 40*
62*
SPP‐70 keV*
90 *
110*
190*
140 144 × 0.4 80 58.8 Qr40 0.4 T3D Pacemaker
40
67
110
120 144 × 0.4 80 56.9 Qr40 0.4* 110 Pacemaker
Bv56 * 1.0*
3.0*
140 144 × 0.4 80 58.8 Qr40 0.4 110 Pacemaker
1.0
3.0

Note: Bold text indicates reconstructions options new for the patient, and not performed for the phantom study. Virtual mono‐energetic images (VMI) from 40 to 190 keV and T3D that indicates poly‐energetic reconstruction, encompassing photon energies ranging from 20 to 120 keV. 13

Abbreviations: Bl, body‐lung; Bv, body‐vascular, higher numeric values indicate increasing sharpness; CTDI, computed tomography dose index volume; IQ, image quality; Qr, quantitative regular; Recon kernel, Reconstruction kernel.

* and ** indicate reconstructions performed for the patient. ** indicates that Bv56 is only applied in combination with Thoracic Coils and Pacemaker preset/90 keV.

Based on the experiences gained from imaging the phantom, a patient protocol was established, which was tested on a patient with an LVAD. The acquisition was made using 120 kVp and IQ level 80. A biphasic contrast injection was used to ensure opacification of all four heart chambers. The first phase had a volume of 65 mL containing 80% iodine contrast (Omnipaque 350 mg I/mL GE Healthcare, Chicago IL, USA) and 20 % saline solution. This was followed by a second phase of 50 mL containing 30% of the same contrast agent and 70% saline solution. A saline chaser of 40 mL finished the injection which was made into an antecubital vein at 5 mL/s. Bolus tracking was used to achieve optimal contrast opacification with region of interest (ROI) placement in the descending aorta. The acquisition was initiated after reaching an increase of 100 HU with a 5 s delay to allow for breath hold instruction. Multiphase reconstructions were made that included reconstructions of the entire scan range at timepoints at every 5% of the cardiac cycle (20 phases in total). Only the best diastolic/systolic phases were included in this study for evaluation.

The resulting images were transferred to the in‐house Picture Archiving and Communication System (PACS). Image analyses were conducted on a standard PACS workstation (IDS7, Sectra Medical Systems GmbH, Linköping, Sweden) and subsequently loaded into ViewDex 3.0 30 for visual grading. For quantitative analysis, Python 3.10 and ParaView 5.11.0 (kitware.com) were used.

2.3. Evaluation of images

A qualitative assessment was performed by six radiologists to determine the presence of metal artifacts and their diagnostic value in various tissues. Additionally, three different methods for the objective quantification of metal artifacts were employed.

2.3.1. Qualitative evaluation: Absolute visual grading

The phantom image and subsequently patient images were showcased to the readers through ViewDex 3.0. This Java‐based software facilitates the presentation and evaluation of anonymized medical images in performance studies involving reviewers. Image cases were randomized by the software and each reader's responses were stored in a distinct log file. 30 , 31 , 32 , 33

Six independent readers assessed 36 phantom image sets and 27 patient image sets. Among them, four were experienced radiologists (20+ years of experience), one had 15 years of experience while the sixth was a junior medical doctor. They graded metal artifacts and their prominence in general (Q1). Since adjustments of imaging parameters may have various effects on image quality, due to different attenuation and tissue properties, the image evaluations were also conducted for different anatomic regions: in the lumen of the LVAD inflow cannula (Q2), cardiac tissue (Q3), lung tissue (Q4 and Q5), and the area around spinal cord (Q6), as shown in Figure 3a. All questions (Q1–Q6) were rated on an absolute 5‐point rating scale. During image review, the readers could adjust the window settings, zoom, and pan. All readers were familiar with the scale in Figure 3b–f before reviewing the images.

FIGURE 3.

FIGURE 3

(a) Shows the areas where diagnostic interpretability was evaluated, Q2: in the lumen of the LVAD inflow cannula, Q3: the cardiac tissue, Q4: left lung tissue, Q5: right lung tissue and Q6: the spinal cord and surrounding tissue. (b–f), shows images with a variety of metal artifacts. (b) massive artefacts, (c) pronounced streaks, (d) minor streaks, (e) minor streaks only at the thickest portions of the metallic implant, (f) indicates the absence of artefacts.

For scoring of general metal artifacts, Question 1 (Q1): a grade of 1 indicates massive artifacts, 2 indicates pronounced streaks, 3 indicates minor streaks, 4 represents minor streaks only at the thickest portions of the metallic implant, while a grade of 5 represents the absence of metal artifacts. In terms of diagnostic interpretability (Q2–Q6): a grade of 1 indicates poor image quality and that the image is not usable, 2 indicates restricted image quality and clear loss of information, 3 indicates sufficient image quality, 4 represents good image quality, while 5 represents excellent image quality. 34

The occurrence of score 3 to 5 for each question (general state or area) and each case (set of imaging parameters) was tallied. Multinominal regressions were performed (package nnet, version 4.2.2, 2022‐10‐31, The R foundation for Statistical Computing) for each of the six questions using kVp, keV, IQ, iMAR, kernel, and slice thickness as predictors. iMAR, keV, and kernel were treated as non‐ordered factors, with iMAR = none, keV = 40, and kernel Qr36f as reference levels. The answers to the questions (score 1−5) were treated as ordered data. For each predictor, a p‐value was calculated where a p‐value < 0.05, was set to indicate statistical significance, indicating that the parameter has an impact on the image quality. The regression coefficient β≠0, and the log odd, the ratio of probability for a score to the probability of score 1 can be calculated using the Equation (1).

lnPscore=2,3,4or5Pscore=1=β0+β1kVp+keVikeVnβ2ikeVi+β3IQ+IMARiIMARnβ4iIMARi+kernelikernelnβ5ikerneli+β6slicethickenss (1)

Inter‐reader agreement was calculated using IntraClass Correlation (ICC) function, two‐way random effects model, average consistency from the irr package in R. Then inter‐reader agreement can be given as Equation (2)

ICCC,kinter=MSRMSEMSR (2)

where MSR is the mean square for between subjects, MSE is the mean square error. Similarly, the intra‐reader agreement was assessed by calculating ICC using average agreement. 35 ICC for intra reader agreements can be given as Equation (3)

ICC2,kintra=MSRMSEMSR+MSC+MSEn (3)

where MSR, MSE is as for Equation (2) and MSC is means square between measurements (raters), and n is the number of cases/subjects. 36

2.3.2. Three methods to quantify metal artifacts

Three distinct approaches were used for metal artifact quantification: manual ROI analysis, Fourier method for streak evaluation, and blooming artifact quantification by segmenting the titanium in the LVAD. These three approaches resulted in four parameters, DiffHU, SDARTIFACT, AmplitudeLowFreq, and BloomVol further described below.

Artifact ROI analysis

The severity of metal artifacts was objectively quantified by computing the absolute deviation in mean attenuation, measured in HU, between an ROI located where the artifact was most pronounced and a comparable structure without the artifact (DiffHU). A larger absolute HU deviation indicates a more pronounced metal artifact. 17 , 37 The ROI was consistently placed in the same region and slice location across all CT image cases. Furthermore, the standard deviation (SD) of the ROI, situated where the metal artifact was most pronounced (SDARTIFACT), could potentially serve as an indicator of artifact extent. Here, higher SD values signify a more substantial artifact load. 38

Linear regression models were used to analyze the relationship between the quantity and the predictors such as kVp, keV, kernel, iMAR, slice thickness, CTDIvol (computed tomography dose index volume), and IQ. The model that provided the best description of the quantity was determined using R and the built‐in step AIC (Akaike Information Criteria) function, as well as an analysis of variance (ANOVA) table. The coefficients for each level of the predictor (factor), except the reference level, represent the percentage change in the predicted value of the quantity when the factor level changes, while keeping all other variables constant. To determine the equation for an optimized model describing the DiffHU, we employed a linear fit for the phantom and a logarithmic linear fit for the patient. Similarly, the model for SDARTIFACT was based on a logarithmic linear fit for both the phantom and the patient.

Quantifying streak artifacts by the Fourier method

The Fourier method derives from the observation that metal objects cause alternating patterns of bright and dark streaks, that can be quantified by a method involving measuring CT values along a contour surrounding the metal, as previously described by Mangold and Hokamp. 35 , 39 , 40 The CT values then undergo a frequency analysis through the discrete Fourier transform. A spectrum with a higher proportion of low frequencies signifies a more intense metal artifact. An in‐house developed Python program was utilized for the analysis, enabling user image selection and automatic contour delineation of the LVAD through thresholding and the “find contour” algorithm. Calculations encompassed three sequential images, with results being averaged. We plotted the HU along the contour, the Fourier of HU along the contour and the corresponding. The amplitude of low frequency, bin1‐2 (AmplitudeLowFreq) was used for further statistical analysis, such as linear regression (as described in the section ROI analysis), and the associated coefficients of variation (CV) were recorded.

Quantifying blooming artifacts by the Volume method

Blooming artifacts arise when metal objects, within imaging, seem larger than their actual size. Therefore, the spatial magnitude of the blooming can be deduced from the depicted object's size, 40 , 41 , 42 , 43 and in this study, it was quantified by determining the LVAD's volume (BloomVol) displayed in the CT images. ParaView 5.11.0 facilitated volume measurement through segmentation. The process incorporated three filtrations:

  1. Initial threshold filtration set a lower boundary at 800 for the phantom (and 2500 for the patient) and an upper boundary of 32 762.

  2. Connectivity filtration was employed in “extract largest region” mode.

  3. The “integrate variable” function computed the volume.

Figure 4 offers a visual representation of the segmentation process.

FIGURE 4.

FIGURE 4

(a) Segmentation after the thresholding of a patient image with kernel Qr56, and (b) after application of connectivity filtration. The BloomVol was obtained by the integrate variable.

Log‐linear regression was employed, as described in the section for ROI analysis, to determine the model for BloomVol for both phantom and patient data set.

3. RESULTS

3.1. Qualitative evaluation: Absolute visual grading

The highest overall diagnostic score, obtained by summing the grades 3 to 5 for all six questions (VGSUM), was 25 for the phantom image cases acquired with both 120 and 140 kVp, IQ 80 and reconstructed with 3 mm slice thickness, quantitative regular kernel, level 40 (Qr40f), iMAR with pacemaker preset and 110 keV (Cases 34 and 36, Table 2). For thin slices (0.4 mm), the achieved highest score was 22, which was obtained for images acquired at 140 kVp, and the same IQ, reconstructing kernel, iMAR preset and keV (Case 8). When examining metal artifacts in general (Q1) separately, the visual grading showed the same results as for Q2–Q6, except that body‐vascular kernel level 40 (Bv40f) also exhibited the fewest metal artifacts (Case 1). For diagnostic interpretability, summing the grades 3 to 5 for Q2–Q6 the poly‐energetic reconstruction (T3D, 20−120 keV), Qr40f, 0.4 mm slice thickness (Case 28), and 110 keV, Qr40f and 3 mm thickness are preferred for the phantom (Cases 34 and 36, Table 2).

TABLE 2.

Description of the phantom image cases and results from the assessment of metal artifacts.

kVp IQ Kernel iMAR VMI (keV) Slice Thickness (mm) DiffHU (metal‐normal) SDARTIFACT (HU) BloomVol (cm3) AmplitudeLowFreq CV (%) Q1 Q2 Q3 Q4 Q5 Q6 VGSUM
Case 1 120 80 Bv40f Ex 110 0.4 −86 50 61.6 42723.6 5.4 5 1 1 2 3 3 15
Case 2 120 80 Bv40f Hi 110 0.4 −66 67 61.2 43578.6 2.3 4 1 3 2 3 4 17
Case 3 120 80 Bv40f Th 110 0.4 −131 141 61.7 44911.3 3.9 2 1 2 0 0 2 7
Case 4 120 80 Bv40f None 110 0.4 −213 128 62.6 40267.9 13.8 1 4 0 0 3 4 12
Case 5 120 80 Bv40f Pa 110 0.4 −134 107 61.6 38909.2 6.6 3 2 3 2 3 4 17
Case 6 120 100 Qr40f Pa 110 0.4 −119 151 59.9 44501.0 11.0 3 2 3 2 4 3 17
Case 7 140 55 Qr40f Pa 110 0.4 −99 99 59.1 52724.3 9.5 4 5 3 1 4 1 18
Case 8 140 60 Qr40f Pa 110 0.4 −51 140 58.5 38961.9 3.4 5 4 3 1 4 5 22
Case 9 120 55 Qr40f Pa 110 0.4 −137 168 61.3 52770.9 4.0 3 2 3 1 4 5 18
Case 10 120 60 Qr40f Pa 110 0.4 −108 150 60.0 39782.8 5.3 3 2 3 2 4 4 18
Case 11 120 80 Bl56f Pa 110 0.4 −45 145 42.3 52021.7 3.5 4 3 2 1 2 1 13
Case 12 120 80 Bv36f Pa 110 0.4 −115 133 62.7 46673.0 13.0 4 3 3 1 3 4 18
Case 13 120 80 Bv40f Pa 110 0.4 −72 120 61.8 41604.8 4.3 2 3 3 2 3 4 17
Case 14 120 80 Bv44f Pa 110 0.4 −103 108 61.2 42936.0 1.6 4 2 3 1 3 4 17
Case 15 120 80 Bv56f Pa 110 0.4 −99 138 56.0 44470.7 5.7 3 1 1 0 2 2 9
Case 16 120 80 Qr36f Pa 110 0.4 −133 123 60.6 42913.5 2.2 4 4 3 1 3 3 18
Case 17 120 80 Qr40f Pa 110 0.4 −115 118 60.2 43677.7 1.8 2 4 4 3 4 3 20
Case 18 120 80 Qr44f Pa 110 0.4 −132 126 58.5 43448.0 3.8 3 4 3 1 4 3 18
Case 19 120 80 Qr40f Pa 40 0.4 −109 207 89.8 37437.5 5.4 0 2 1 0 1 0 4
Case 20 120 80 Qr40f Pa 62 0.4 −86 134 84.6 39828.3 5.7 0 4 1 0 3 3 11
Case 21 120 80 Qr40f Pa 190 0.4 −108 158 52.6 47422.1 1.1 2 2 3 1 2 3 13
Case 22 120 80 Bv40f None 70 1 −150 165 80.0 38917.6 0.8 2 4 3 2 5 5 21
Case 23 120 80 Qr40f None 70 1 −143 170 NA 40270.2 1.3 3 5 1 2 3 3 17
Case 24 120 80 Qr40f None T3D 0.4 46 211 83.3 43657.8 3.0 0 1 1 1 4 3 10
Case 25 140 80 Qr40f Pa 40 0.4 −273 275 92.7 45531.2 7.0 0 3 0 0 1 1 5
Case 26 140 80 Qr40f Pa 67 0.4 −141 143 81.5 46290.3 7.0 1 3 0 0 1 1 6
Case 27 140 80 Qr40f Pa 110 0.4 −121 96 59.6 56096.3 5.5 3 4 3 1 3 3 17
Case 28 140 80 Qr40f Pa T3D 0.4 −142 129 75.0 55114.1 3.4 3 6 3 3 5 3 23
Case 29 90 80 Qr40f Pa 110 0.4 −14 147 65.2 45112.8 2.2 1 0 3 0 2 1 7
Case 30 90 80 Qr40f Pa T3D 0.4 −170 199 85.0 45160.2 7.1 0 4 1 0 2 1 8
Case 31 120 80 Bv40f Pa T3D 0.4 −140 141 79.0 49692.4 3.0 3 5 3 1 4 3 19
Case 32 120 80 Qr40f Pa 110 0.4 −39 137 60.3 48914.2 1.5 3 4 3 1 4 4 19
Case 33 120 80 Qr40f Pa 110 1 −123 108 60.3 50246.3 2.4 3 5 3 3 3 3 20
Case 34 120 80 Qr40f Pa 110 3 −136 108 61.8 48888.0 3.7 5 4 6 2 5 3 25
Case 35 140 80 Qr40f Pa 110 1 −97 89 59.4 51022.6 2.7 4 5 3 3 4 3 22
Case 36 140 80 Qr40f Pa 110 3 −140 81 60.8 51012.5 5.4 5 5 3 3 5 4 25

Note: The acquisition parameters, kVp and IQ (image quality) level, and the reconstruction parameters, kernel, iMAR (iterative metal artifact reduction), and virtual mono‐energetic image (VMI), varied across the image cases. The results from manual ROI analyses included the difference in Hounsfield Units (HU) between areas with metal artifacts and normal tissue (DiffHU—Metal minus normal), and the standard deviation in areas affected by metal artifacts (SDARTIFACT). The volume from the blooming assessment (BloomVol) and the results from the streak artifact assessment, the amplitude of low frequencies in bin 1−2 (AmplitudeLowFreq) and the associated coefficient of variation (CV). The occurrence of grade 3, 4, and 5 responses for visual grading of metal artifact (Q1) and diagnostic interpretability (Q2–Q6), and their respective sums (VGSUM).

In the multinominal regression analysis of the visual grading results, considering the acquisition and reconstructions parameters for the phantom images, it was observed that selection of the virtual mono‐energetic (keV) had a more pronounced impact on the grading of Q1–Q6 than the selection of kVp. This was indicated by a higher relative probability ratio given by Equation (1). Selecting 110 keV seems to elevate the probability of achieving a score of 4 for all questions, except Q5 (spinal area). The choice of iMAR preset for extremities and hip implants is most effective to reduce metal artifacts (Q1). However, these iMAR presets result in a reduction of the image quality as reflected in Q4–Q6 (lung tissue and spinal cord). Kernel Qr44f and Bv56f are most effective in mitigating metal artifacts (Q1). The selection of kernel appears to have negligible impact when assessing the lumen of the LVAD (Q2). For the evaluation of cardiac tissue (Q3), Bv36f proves to be the optimal choice, Qr40f for lung tissue (Q4–Q5) and spinal area (Q6). Increasing the slice thickness has a positive effect on the assessment, particularly for Q2 and Q5 (see Table A1).

In the in vivo dataset, the highest score achieved was 14, resulting from the reconstruction of 0.8 and 3 mm slice thickness and pacemaker preset, kernel Bv56f, and T3D (Cases 26 and 27, Table 3). For 0.4 mm slices, a score of 11 was achieved for two settings, kernel Qr40f, 110 keV along with iMAR preset for thoracic coils and hip implants (Cases 18 and 20). For addressing metal artifacts (Q1), 110 keV, body‐lung level 56 (Bl56f), 0.4 mm slice thickness, and T3D, Bv56f, 0.8/3 mm slice thickness are preferable (Cases 12, 26, and 27). However, for diagnostic interpretability Q2–Q6, the Bv56f and the same setting as for Q1 proved to be preferable (Cases 26 and 27).

TABLE 3.

Description of the patient image cases and results from the assessment of metal artifacts.

Kernel iMAR VMI (keV) Slice thickness (mm) DiffHU (metal‐normal) SDARTIFACT (HU) BloomVol (cm3) AmplitudeLowFreq CV (%) Q1 Q2 Q3 Q4 Q5 Q6 VGSUM
Case 1 Qr40f Pa 40 0.4 776 187 96.3 69478.9 12.4 0 0 0 0 1 0 1
Case 2 Qr40f Pa 62 0.4 396 121 73.5 37266.1 1.5 0 0 0 0 0 0 0
Case 3 Qr40f Pa T3D 0.4 331 75 54.7 23155.9 1.1 1 0 1 0 3 4 9
Case 4 Qr40f Pa SSP‐70 0.4 446 113 62.5 40961.9 11.4 0 0 0 0 3 0 3
Case 5 Qr40f Pa 90 0.4 308 59 49.1 26209.7 2.6 0 0 0 0 2 1 3
Case 6 Bv56f Pa 90 0.4 428 104 46.4 45695.2 9.4 0 0 0 0 3 1 4
Case 7 Qr40f Pa 190 0.4 304 80 35.3 35855.6 5.2 0 0 0 0 2 2 4
Case 8 Qr36f Pa 110 0.4 339 137 43.2 21071.3 19.1 1 0 0 0 4 2 7
Case 9 Qr40f Pa 110 0.4 268 77 42.8 18676.3 14.1 0 0 0 0 3 1 4
Case 10 Qr44f Pa 110 0.4 360 75 42.4 31958.9 14.1 1 0 0 0 3 1 5
Case 11 Qr56f Pa 110 0.4 397 104 40.2 40797.9 11.7 0 0 0 0 2 2 4
Case 12 Bl56f Pa 110 0.4 355 102 37.2 51823.4 13.8 2 0 0 0 3 2 7
Case 13 Bv36f Pa 110 0.4 350 134 43.5 22780.7 10.3 0 0 0 0 2 1 3
Case 14 Bv40f Pa 110 0.4 286 58 43.1 21459.0 16.8 0 0 0 0 4 2 6
Case 15 Bv44f Pa 110 0.4 340 70 42.8 39596.0 9.8 0 0 0 0 2 2 4
Case 16 Bv56f Pa 110 0.4 373 88 40.6 44783.1 14.0 0 0 0 0 0 0 0
Case 17 Qr40f None 110 0.4 86 37 42.9 37359.9 4.9 0 0 0 0 3 0 3
Case 18 Qr40f Tc 110 0.4 211 94 42.8 15596.6 22.8 1 1 1 2 5 1 11
Case 19 Qr40f Ei 110 0.4 416 106 42.8 17471.6 13.3 1 0 1 1 4 3 10
Case 20 Qr40f Hi 110 0.4 398 108 42.8 16930.1 17.9 1 0 1 1 4 4 11
Case 21 Bv56f Tc 110 0.4 127 64 40.6 57752.4 12.3 0 0 0 0 4 1 5
Case 22 Bv56f Pa 110 1 411 98 34.4 39611.4 12.3 0 0 1 1 5 3 10
Case 23 Qr40f Pa 110 1 277 77 36.3 17451.3 3.2 1 0 0 0 4 2 7
Case 24 Bv56f Pa 110 3 317 89 27.0 29432.3 32.6 1 0 1 2 4 3 11
Case 25 Qr40f Pa 110 3 264 75 28.7 15987.0 26.2 0 0 0 1 5 1 7
Case 26 Bv56f Pa T3D 0.8 321 101 50.1 35135.6 5.0 2 2 2 1 5 2 14
Case 27 Bv56f Pa T3D 3 342 102 37.1 28447.4 19.9 2 2 2 1 4 3 14

Note: The acquisition parameters were IQ (image quality) level 80 and 120 kVp. The reconstruction parameters, kernel, iMAR (iterative metal artifact reduction), virtual mono‐energetic image (VMI) and slice thickness, varied across the image cases. The results from manual ROI analyses included the difference in Hounsfield Units (HU) between areas with metal artifacts and normal tissue (DiffHU—Metal minus normal), and the standard deviation in areas affected by metal artifacts (SDARTIFACT). The volume from the blooming assessment (BloomVol) and the results from the streak artifact assessment, the amplitude of low frequencies in bin 1−2 (AmplitudeLowFreq) and the associated coefficient of variation (CV). The occurrence of grade 3, 4 and 5 responses for visual grading of metal artifact (Q1) and diagnostic interpretability (Q2–Q6), and their respective sums (VGSUM).

In the multinominal regression analysis of patient image visual grading, it was observed that 110 keV and T3D had a significantly positive effect on both metal artifacts (Q1) and on diagnostic interpretability, Q2–Q6. The iMAR preset for Extremities seems to ameliorate metal artifacts (Q1), but shows contrasting effect on Q2, Q4, and Q6. Specifically, for the evaluation of lumen of LVAD (Q2) pacemaker and thoracal presets are preferable. For the lung opposite to the LVAD (Q5), it appeared that either the extremities or hip implants presets offered the best image quality. The kernels Bl56f and Bv44f reduce the metal artifacts (Q1). However, for the lumen (Q2) the kernels did not significantly impact grading and were therefore excluded from the model. For cardiac tissue (Q3), kernel Bv56f and Qr40f have a positive impact. The kernels had a statistically significant impact on the Q5 (right lung), with Bv40f likely providing the best image quality, while Bv56f improved the image quality in the spine area (Table A2).

The inter‐reader reliability, expressed as ICC (intraclass correlation coefficient), ranged from 0.54 to 0.85 for the different questions in the phantom study, and similar range of 0.24 to 0.7 for the patient. See Table 4 for ICC values, p‐values and confidence intervals associated with all the questions (Q1–Q6).

TABLE 4.

Inter reader agreement for phantom study and the patient calculated by ICC two way consistency average.

Q1 Q2 Q3 Q4 Q5 Q6
Phantom
ICC 0.852 0.538 0.782 0.653 0.696 0.631
p‐value < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
CI (0.722, 0.911) (0.285, 0.723) (0.664, 0.87) (0.463, 0.792) (0.53, 0.818) (0.43, 0.779)
Patient
ICC 0.539 0.239 0.363 0.524 0.698 0.405
p‐value 0.0024 0.161 0.0526 0.00347 < 0.001
CI (0.205, 0.763) (−0.312, 0.61) (−0.098, 0.673) (0.18, 0.756) (0.479, 0.845) (−0.025, 0.695)

Abbreviations: CI, confidence interval; ICC, IntraClass Correlation.

In terms of intra‐reader reliability, all questions except Q2 had a higher ICC value than 0.86. The highest intra‐reader reliability was observed for Q1 with an ICC of 0.981, p‐value of 4.37e‐10, and a confidence interval (CI) of (0.935, 0.997). On the other hand, the lowest intra‐reader reliability was found for Q2 with ICC = 0.678, p = 0.0427 and CI = (−0.181, 0.951).

3.2. Metal artifact quantification

3.2.1. ROI analyses

In the phantom cases, we found that the HU value of lung tissue affected by metal artifacts was lower than that of normal tissue, while the opposite was observed in‐vivo. Among the iMAR presets, kernels, IQ settings, and keV levels, the minimum DiffHU was observed for 90 kVp, the pacemaker preset, the Qr40f kernel, IQ80, and 110 keV in the phantom datasets. In the in‐vivo data, the minimum DiffHU was found for 120 kVp, no IMAR, the Qr40f kernel, and 110 keV. Similarly, the SDARTIFACT was minimized in the phantom cases with 120 kVp, the extremities iMAR, the Bv40f kernel, IQ80, and 110 keV. In the in‐vivo datasets, the lowest SDARTIFACT was found in the same image settings as for DiffHU (refer to Table 2 and Table 3).

Both DiffHU and SDARTIFACT are influenced by the selection of iMAR presets and kernels (see Figure 5c–d). In the in‐vivo dataset, the thoracal preset reduced DiffHU the most, while the pacemaker preset had the most pronounced reduction for the phantom. However, the pacemaker preset reduced SDARTIFACT mostly for the patient, and the extremity preset for the phantom. Increasing kVp decreased both DiffHU and SDARTIFACT. This trend was similar for keV, although there were some outliers as indicated in Figure 5a–b. However, the predictors were not as effective in describing DiffHU as they were for SDARTIFACT (refer to adjusted R‐squared in Table 5) and the model adequacy is better for the patient data. Increasing slice thicknesses and dose (IQ) reduced the SDARTIFACT as expected, refer to Table A3 for all regression coefficients and associated p‐values for the models given in Table 5.

FIGURE 5.

FIGURE 5

The change (β) in (a) DiffHU and in (b) SDARTIFACT as function of keV relative to 40 keV and kVp. The change (β) in (c) DiffHU and in (d) SDARTIFACT as function of kernel relative to Qr36f and as function of iMAR relative to no iMAR.

TABLE 5.

Regression model for two approaches to measure metal artifacts: DiffHU and SDARTIFACT, both based on ROI analyses.

Phantom Patient
Measured quantity Optimized regression model Model adequacy (Adjusted‐R2 ) Optimized regression model Model adequacy (Adjusted‐R2 )

DiffHU

Deviation between HU in lung tissue with and without metal artifact

DiffHU=β0+β1kVp+β2keV+β3sw+β4IMAR+β5kernel+β6IMAR:kernel+β7kernel:keV+ε
0.280
DiffHU=keVβ1·swβ2·IMARβ3·kernelβ4·IMAR:kernelβ5·kernel:keVβ6·e(β0+ε)
0.949

SDARTIFACT

Standard deviation in lung tissue with metal artifact.

SDARTIFACT=kVpβ1·keVβ2·IQβ3·swβ4·IMARβ5·kernelβ6·IMAR:kernelβ7·kernel:keVβ8·e(β0+ε)
0.755
SDARTIFACT=keVβ1·swβ2·IMARβ3·kernelβ4·IMAR:kernelβ5·kernel:keVβ6·e(β0+ε)
0.982

3.2.2. Streak artifacts

The amplitude for the sum of bin 1−2 (AmplitudeLowFreq), which corresponds to frequencies ranging from 0 to 0.0142, is presented in Table 2 and Table 3, along with the associated coefficient of variation. Figure 6 displays the contour and frequency plot for both phantom and patient images, categorized as good and bad based on visual grading analyses. The lowest AmplitudeLowFreq is observed for 120 kVp, pacemaker iMAR, Qr40f kernel, IQ80, and 40 keV in the phantom. In the patient settings, the lowest AmplitudeLowFreq was observed for the iMAR preset for thoracic coils, Qr40f kernel, and 110 keV.

FIGURE 6.

FIGURE 6

An exemplification of the Fourier representation exhibiting high image quality, as per visual grading results: (a) Case 36 for phantom and (b) Case 12 for the patient. Conversely, examples of suboptimal image quality (c) phantom, Case 24 and (d) for the patient, Case 16.

Table 6 provides the regression model for the AmplitudeLowFreq. The model adequacy is poor for the phantom data, and excellent for the patient data. In the case of the patient, the AmplitudeLowFreq tends to increase for increasing kVp and decreasing with keV. Sharper kernel tends to increase the AmplitudeLowFreq (refer to Figure 7). See Table A4 for all regression coefficients and associated p‐values for the models given in Table 6.

TABLE 6.

Regression model for assessing metal streak artifacts by AmplitudeLowFreq, and blooming artifact by BloomVol.

Phantom Patient
Measured quantity Optimized regression model Model adequacy (Adjusted‐R 2) Optimized regression model Model adequacy (Adjusted‐R2 )

AmplitudeLowFreq

Streak artifacts by amplitude of low frequencies

bin 1−2

AmplitudeLowFreq=β0+β1kVp+β2keV+β3sw+ε
0.2937
AmplitudeLowFreq=β0+β1keV+β2sw+β3kernel+β4IMAR+β5keV:sw+β6keV:kernel+ε
0.9952

BloomVol

Spatial distortion by volumetric representation of LVAD

BloomVol=kVpβ1·keVβ2·kernelβ3·imarβ4·sliceβ5·e(β0+ε)
0.9893
BloomVol=·keVβ1·kernelβ2·imarβ3·sliceβ4·e(β0+ε)
0.9889
FIGURE 7.

FIGURE 7

The change (β) in (a) AmplitudeLowFreq and in (b) BloomVol as function of keV relative to 40 keV and kVp. The change (β) in (c) AmplitudeLowFreq and in (d) BloomVol as function kernel relative to Qr36f and as function of iMAR relative to no iMAR.

3.2.3. Blooming artifacts

The LVAD volume (BloomVol) ranged from a minimum of 42.3 to 92.7 cm3 in the phantom datasets, as presented in Table 2. In the in‐vivo datasets, the BloomVol varied from 27.0 to 96.3 cm3 as presented in Table 3. The optimized model for BloomVol with respect to kVp, keV, kernel, and iMAR is given by the equations in Table 6. The BloomVol can be adequately described by the parameters included in the model, with an adjusted R2 value of 0.9893 for the phantom and 0.9889 for the patient.

Sharper kernels with higher kernel numbers contribute to a smaller BloomVol, as do higher kVp and keV values. The selection of iMAR does not have a statistically significant effect on BloomVol (except for the pacemaker iMAR on phantom images), nor do CTDIvol and IQ. Therefore, the blooming artifact is dependent on the following factors, ranked from the largest impact to the least impact: kVp, kernel, keV, and iMAR. The change in BloomVol as a function of keV, kV, iMAR, and kernel is illustrated in Figure 7. The impact of slice thickness was not significant in the model.

3.3. Correlation between different assessments methods

In the phantom datasets, there was a negative correlation of −0.39 between the VGSUM and the SDARTIFACT. Additionally, there was a correlation between the VGSUM and the BloomVol, with a correlation coefficient of −0.31. However, the correlation between Q1 (metal artifacts) and SDARTIFACT was stronger, with correlation coefficients of −0.58, and −0.53 between Q1 and BloomVol. Furthermore, there was a moderate negative correlation between Q3 (cardiac tissue) and SDARTIFACT (−0.33), as well as the BloomVol (−0.34).

In the in‐vivo datasets, there was a negative correlation between the VGSUM and the BloomVol, with a correlation coefficient of −0.40. There was also a correlation of −0.48 between the VGSUM and the AmplitudeLowFreq, a correlation between the AmplitudeLowFreq and the assessment of the lung closest to the LVAD (Q4), with a correlation coefficient of −0.43. Additionally, there was a correlation between the AmplitudeLowFreq and the assessment of lung tissue (Q5), with a correlation coefficient of −0.49. The correlation between DiffHU and the visual grading was weak for all questions for both the phantom and patient (refer to Table 7).

TABLE 7.

For phantom and patient study: Correlation between visual grading (score for Q1–Q6, and the sum of score VGSUM) and objective metal artifact assessment DiffHU (HU), SDARTIFACT (HU), BloomVol (cm3) and AmplitudeLowFreq.

Phantom VGSUM Q1 Q2 Q3 Q4 Q5 Q6 DiffHU SDARTIFACT BloomVol Amplitude LowFreq
Patient rho p‐value rho p‐value rho p‐value rho p‐value rho p‐value rho p‐value rho p‐value rho p‐value rho p‐value rho p‐value rho p‐value
VGSUM 0.626 0.000 0.607 0.000 0.790 0.000 0.742 0.000 0.816 0.000 0.569 0.000 −0.084 0.594 −0.389 0.010 −0.305 0.050 0.105 0.503
Q1 0.772 0.000 0.198 0.204 0.480 0.001 0.489 0.001 0.410 0.006 0.363 0.017 0.163 0.295 −0.576 0.000 −0.529 0.000 0.126 0.422
Q2 0.535 0.004 0.534 0.004 0.230 0.139 0.285 0.064 0.418 0.005 0.110 0.482 −0.411 0.006 −0.261 0.091 −0.083 0.600 0.288 0.061
Q3 0.807 0.000 0.639 0.000 0.638 0.000 0.619 0.000 0.603 0.000 0.437 0.003 0.144 0.358 −0.333 0.029 −0.344 0.026 0.108 0.489
Q4 0.767 0.000 0.470 0.013 0.551 0.003 0.821 0.000 0.646 0.000 0.425 0.005 0.086 0.582 −0.366 0.016 −0.243 0.121 −0.056 0.723
Q5 0.849 0.000 0.489 0.010 0.439 0.022 0.587 0.001 0.719 0.000 0.479 0.001 −0.036 0.819 −0.204 0.190 −0.137 0.385 0.026 0.868
Q6 0.785 0.000 0.571 0.002 0.145 0.470 0.651 0.000 0.458 0.016 0.471 0.013 −0.002 0.992 −0.265 0.086 −0.146 0.355 −0.254 0.100
DiffHU −0.159 0.427 −0.069 0.731 −0.201 0.315 0.124 0.537 −0.090 0.655 −0.323 0.101 0.103 0.609 −0.110 0.483 −0.350 0.023 −0.112 0.476
SDARTIFACT −0.011 0.955 0.169 0.401 0.086 0.669 0.136 0.499 0.135 0.501 −0.111 0.583 −0.002 0.991 0.457 0.016 0.370 0.016 −0.260 0.092
BloomVol −0.396 0.0410 −0.149 0.459 0.044 0.829 −0.111 0.580 −0.358 0.067 −0.340 0.083 −0.410 0.034 0.398 0.040 0.277 0.162 −0.224 0.154
AmplitudeLowFreq −0.477 0.0120 −0.338 0.0843 −0.198 0.323 −0.318 0.107 −0.433 0.024 −0.487 0.010 −0.350 0.074 0.293 0.138 0.100 0.621 0.098 0.628

Abbreviations: SDARTIFACT , standard deviation in areas affected by metal artifacts; VGSUM, visual grading of metal artifact.

3.4. Examples of patient image cases

Figure 8 shows the PCCT patient images with highest and lowest total score from visual grading for cardiac and lung tissue, as well as the inflow and outflow cannula. The inflow cannula (Q2) and cardiac tissue (Q3) obtained the highest score with Bv56 and T3D, as for the total score. However, the lung tissue closest to the LVAD was best visualized using 110 keV and kernel Qr40f or Bv56f, while the other lung has high score for both T3D, Bv56 and 110 keV, Qr40f. The spinal cord area achieved the highest score for 110 keV, Bv56, and iMAR with hip preset.

FIGURE 8.

FIGURE 8

An example of the lowest image quality, Case 2 (62 keV, Qr40f, 0.4 mm) and highest image quality Case 27 (T3D, Bv56f, 3 mm) of: (a) and (e) cardiac tissue, (b) and (f) lung tissue, (c) and (g) inflow cannula and (d) and (h) outflow cannula.

4. DISCUSSION

In this study, we optimized PCCT for cardiac imaging in LVAD patients, where the proximity of metal close to the region of interest adversely affects image quality. We evaluated 36 different exposure and reconstruction settings in a thoracic phantom and 27 reconstructions in an in‐vivo dataset of a patient with an LVAD implant. Six radiologists visually assessed the images and metal artifacts were assessed using three established objective quantitative methods.

Regarding the three quantitative metal artifact assessment methods—artifact HU analysis, Fourier analysis, and blooming volume—the model adequacy was moderate for the phantom datasets, except for the blooming artifact quantification, which was well‐fitted. Conversely, the in‐vivo data had good fit for all quantities which means that kVp, VMI (keV) level, kernel, iMAR, and slice thickness effectively explain the variations in DiffHU, SDARTIFACT, AmplitudeLowFreq, and BloomVol. The absolute HU difference in the in‐vivo datasets was approximately 340, aligning with a prior study examining metal artifacts in the spine, shoulder, or extremity implants. 17 In the in‐vivo datasets, the difference in HU decreased as the keV increased, showing reduced measured metal artifact (DiffHU) with higher keV settings. This concurs with findings by Bamberg et al. 37 which demonstrated a decrease in absolute HU values with increasing keV. However, the phantom datasets displayed the opposite trend. This inconsistency, coupled with poor model adequacy may stem from the uneven contrast distribution in the cadaver lamb cardiac phantom. Thus, caution is advised when comparing patient and phantom outcomes. Additionally, there is a fundamental difference between the quantitative methods when it comes to the amount of data involved in the analysis. DiffHU and SDARTIFACT are based on only one image in the series, while AmplitudeLowFreq is an average of three images, and BloomVol is based on the whole image series. Hence BloomVol has better premises to reflect the artifacts throughout the series.

The correlations between the visual grading and three quantitative methods ranged from weak to good, but some inconsistencies were evident here as well between the in‐vivo datasets and the phantom datasets. Notably, there was better inter‐reader agreement for the phantom‐dataset compared to the in‐vivo dataset. This disparity might stem from clearer phantom reading instructions and the fact that some radiologists perhaps focused on the most problematic image in the series, while others averaged their assessment across all images. The correlation between the visual grading of metal artifacts and DiffHU was weak and lacked statistical significance for both phantom and the in‐vivo dataset, aligning with Hokamp et al. 35 to use the Fourier method. The Fourier method had strong negative correlation to the visual grading of metal artifact and diagnostic interpretability (VGSUM) and visual grading for metal artifacts separately (Q1), for the patient, but weak correlation to data for the phantom. Nonetheless, this study's correlation coefficient was good, whereas Hokamp et al. 35 observed an excellent correlation. Thus, additional patient data may be required to evaluate the efficacy of the Fourier method.

SDARTIFACT had a strong negative correlation with the VGSUM and the subjectively assessed metal artifacts in phantom datasets. However, the model adequacy was poor for the phantom. For the patient, SDARTIFACT had a weak or no correlation to the questions in the visual grading. This is in accordance with the findings by Hokamp et al. 35 that SDARTIFACT provided slightly better correlation than DiffHU to visual grading. Finally, BloomVol showed strong negative correlation to the VGSUM for both phantom and in‐vivo data and showed a very good model adequacy for both the phantom and patient. Hence, the volume of the metal object, BloomVol, is considered the most robust and accurate quantitative indicator for the severity of metal artifacts, while the Fourier method for assessing streak artifacts may also be effective.

The quantitative as well as visual assessment of the phantom acquisition revealed that optimal image quality was achieved using acquisitions with 120 kVp and IQ 80. Mergen et al. 44 and Aquino et al.20used 120 kVp, and IQ 68 for thoracoabdominal aorta and IQ 50 for a late enhancement cardiac scan, while Euler at al. 45 chose 120 kVp and IQ 58 for thoracoabdominal aorta. Rajendan et al. 13 also chose 120 kVp for a coronary CT angiography. Considering the large amount of metal in LVAD patients, a higher IQ is expected to be favorable in this patient group. In the current study, it was noted that the choice of IQ which affects the mAs (higher IQ, higher mAs) had minimal impact on metal artifacts in the phantom. However, CTDIvol was observed to increase linearly up to an IQ of 100, after which it decreased, while effective mAs increased linearly with IQ level, as expected. CTDIvol was lower for IQ 100 since this scan coincidentally was scanned for 60%−80% of the cardiac cycle instead of 0%−100% as for the other IQ levels.

Visual grading analyses of phantom and patient data showed improved image quality for all anatomic areas evaluated using T3D reconstruction. That is in good agreement to the study of Rajendran et al. 13 where T3D was selected for abdominopelvic and bone images, while they use VMIs for coronary CT. They claim that using 65 keV or higher level of VMIs reduces the calcium blooming artifact, while our study found that 110 keV reduces the LVAD blooming artifact most.

We found that the image quality was affected more by the reconstructed VMI level (keV) than the chosen kVp. This observation may stem from the exclusion of low kVp settings, because an initial exploration showing low kVp settings caused insufficient image quality. However, current results are in alignment with the phantom study by Skornitzke et al., 46 who found that the impact of increasing the tube potential to 140 kVp was low for light metals such as titanium and aluminum.

We found that kernel Qr40 was beneficial for the phantom data set, while kernel Bv56 gave the best image quality for the in‐vivo data. Rajendran et al. 13 applied kernel Bv48 for VMIs and Qr40 for quantitative images (iodine map and virtual none contrast) for coronary arteries. Mergen et al. 44 reconstructed VMIs at 65 keV, using QIR 3, kernel Qr40, and 1.5 mm slice thickness. Likewise, Rajendran used Qr40 as basis for quantification of extracellular volume. In a phantom study, Skornitzke et al. 46 compared two kernels using a ROI analysis based on HU numbers. They observed that using kernel body regular 36 (Br36) led to reduced metal artifacts compared to the Br56. However, no significant differences in shape distortion were observed between Br36 and Br56. In contrast, our study found that the Bv56 kernel performed better in terms of visual grading and blooming artifact reduction for in‐vivo data. However, for the phantom dataset, the Bv36 kernel received higher grades compared to the Bv56 kernel. Using PCCT for evaluation of coronary plaques and stents in a phantom model, performed by Rajagopal et al., 47 kernel U70f showed to outperform B46f, and in the study performed by Elias et al., 48 Bv72 was superior to Bv64, while there was no significant difference between Bv64 and Bv56. The kernel level 36 is expected to produce smoother images than 56, potentially reducing streak artifacts while enhancing blooming artifacts. Small structures consisting of highly attenuating material are sensitive to blooming artifacts, hence sharp kernels, such as Bv72 are preferred.

The volumetric model used for measuring the blooming artifact revealed that iMAR had less effect on image quality than the kVp, kernel and keV. iMAR offers various presets, but none of them are specifically designed for LVAD metal. Consequently, we applied different presets, in contrast to Anhaus et al., 49 who exclusively used MAR presets for dedicated metal, adhering to the preset nomenclature. Among the available presets, we found that the pacemaker preset yielded the most favorable results overall. This is in good agreement with Aissa et al. 25 who found pacemaker preset preferable for LVAD imaging using an energy integrated detector. While some other presets showed promise in certain image slices, they were associated with limitations in others. However, we find that the combination of VMI and iMAR is beneficial for PCCT imaging in LVAD patients, corroborating the findings of Anhaus et al. 49 In the case of the Hip preset, Anhaus et al. 49 did not observe any qualitative or quantitative enhancement with energies exceeding 100 keV for hip implants. As for the spine, the optimal VMI was found to be at 100 keV. Our results align with these findings, indicating that 110 keV is the optimal choice. We found that the selection of conventional MAR did not improve the metal artifacts as much as the selection of kVp, keV, and kernel; the use of iMAR strongly reduced the metal artifacts, which agrees with Aissa et al., 25 Skornitzke et al., 46 and Anhaus et al. 49

PCCT is expected to replace conventional CT partially and maybe even completely, initially for applications where it leads to major improvements in image quality. Our evaluation is a first step in this technological diagnostic leap for patients with LVADs, where it can bring benefits such as improved image quality to better device assessment and allows clinicians to accurately assess its position, integrity, and functioning at lower iodine contrast and radiation dose compared to conventional CT. Given that patients with LVADs are at an increased risk of kidney dysfunction, this capability could yield an important ability to conduct scans more safely in this patient group. Traditionally, flow monitoring and cardiac optimization for LVAD is performed with echocardiography. Our study shows that PCCT with optimal metal reduction settings, performed well in imaging and future retrospective images may be used to complement or replace echocardiography for regular scans and monitor changes. This longitudinal assessment facilitates tracking device performance, detect any evolving issues, and guide treatment adjustments.

One of the main limitations of this study was that the phantom was not anthropometric regarding iodine distribution, and the phantom images were not optimal due to the lungs not being fully expanded. However, as the location of the LVAD in relation to the heart muscle and blood pool has a large effect on the image quality, the use of biological materials (lamb) in combination with the chosen phantom setup is still considered to be the most optimal option to investigate the acquisition settings for a patient with LVAD. The effect of motion, the position and orientation of the LVAD, and the pump‐speed were not investigated in this study. Nevertheless, research conducted by Holmes et al. 22 demonstrated that PCCT imaging retains spatial resolution and HU accuracy even when imaging objects in motion. Furthermore, only level 4 of QIR was evaluated. This was, however, previously shown to be the optimal reconstructions setting for coronary artery calcium scoring by Zsarnocazy et al. 19 This in‐vivo study was limited to one patient, it is nevertheless the first time this patient group has been examined using PCCT, leading to valuable insights in the utility of PCCT within this patient population, contributing to the advancement of the field.

Reading images for follow‐up LVAD patients is a rather complex task, as it involves visualization of various tissues, also in proximity to large metal components. Consequently, radiologists may need to read several different reconstructions, as well as using different window levels and window width. We found two reconstructions methods that reduce metal artifacts and provide sufficient diagnostic interpretability. Nevertheless, it appears that the visibility of artifacts is primarily affected by keV and the reconstruction kernel, including the reconstruction matrix and how the raw data is collected and processed per pixel. Therefore, a better combination of MAR algorithms and reconstruction kernels may further improve the image quality. Ongoing research focuses on improving MAR algorithms, including the interpolation method and the utilization of both sinogram and image domains, as well as incorporating deep learning techniques. 50 However, PCCT represents a technology that is new in the commercial market, and is therefore, as is the case with other new technologies, rapidly developing with a high rate of updates expected in the near future.

5. CONCLUSION

Our findings indicate that acquisition at 120 kVp with an IQ of 80, and subsequent reconstruction using either VMI 110 keV or T3D provides the highest image quality in patients with an LVAD. Optimal reconstruction kernels for visual assessment are Qr40f and Bv56f, while pacemaker iMAR preset should be employed. A slice thickness of 3.0 mm with overlap is advised for overall assessment. The volume of LVAD to measure blooming was shown to be the best objective method to assess metal artifacts, while the Fourier method for assessing streak artifacts was also shown to be effective. Overall, PCCT has the potential to revolutionize the evaluation of patients with left ventricular assist devices by offering improved image quality and thereby augmented device assessment.

AUTHOR CONTRIBUTIONS

Bente Konst: Conceptualization; methodology; acquisition of phantom scans; data processing; statistical analysis; visualization; drafting of the manuscript. Linus Ohlsson: Methodology; phantom development; visual assessment of images; visualization; drafting of the manuscript. Lilian Henriksson: Protocol development and acquisition of patient scans; drafting of the manuscript. Mårten Sandstedt: Visual assessment of images; interpretation of results; drafting of the manuscript. Anders Persson: Conceptualization; methodology; visual assessment of images; critical revision of the manuscript. Tino Ebbers: Conceptualization; methodology; critical revision of the manuscript. All the authors reviewed the manuscript and approved the final submission.

CONFLICT OF INTEREST STATEMENT

The authors have no conflict of interest to disclose.

DATA AVAILABILTIY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Supporting information

Supporting Information

ACM2-25-e14386-s001.docx (73.9KB, docx)

ACKNOWLEDGMENTS

This work has been conducted within Center for Medical Image Science and Visualization (CMIV) at Linköping University, Sweden. CMIV is acknowledged for provision of financial support and access to leading edge research infrastructure. Furthermore, the work was funded by Swedish Research Council (# 2022−03931), Swedish Heart and Lung Foundation (# 20210441), ALF Grants Region Östergötland (# RÖ‐987498), Sweden's Innovation Agency VINNOVA (# 2019‐ 02261) and Foundation Linköpings Läkaresällskap Research Fund.

Konst B, Ohlsson L, Henriksson L, Sandstedt M, Persson A, Ebbers T. Optimization of photon counting CT for cardiac imaging in patients with left ventricular assist devices: An in‐depth assessment of metal artifacts. J Appl Clin Med Phys. 2024;25:e14386. 10.1002/acm2.14386

REFERENCES

  • 1. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart. 2000;83(5):596‐602. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Dharmarajan K, Rich MW. Epidemiology, pathophysiology, and prognosis of heart failure in older adults. Heart Fail Clin. 2017;13(3):417‐426. [DOI] [PubMed] [Google Scholar]
  • 3. Le Pavec J, Hascoët S, Fadel E. Heart‐lung transplantation: current indications, prognosis and specific considerations. J Thorac Dis. 2018;10(10):5946‐5952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Vieira JL, Ventura HO, Mehra MR. Mechanical circulatory support devices in advanced heart failure: 2020 and beyond. Prog Cardiovasc Dis. 2020;63(5):630‐639. [DOI] [PubMed] [Google Scholar]
  • 5. Jorde UP, Saeed O, Koehl D, et al. The society of thoracic surgeons intermacs 2023 annual report: focus on magnetically levitated devices. Ann Thorac Surg. 2024;117(1):33‐44. [DOI] [PubMed] [Google Scholar]
  • 6. Aissaoui N, Morshuis M, Maoulida H, et al. Management of end‐stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes. Eur J Cardiothorac Surg. 2018;53(1):170‐177. [DOI] [PubMed] [Google Scholar]
  • 7. Stainback RF, Estep JD, Agler DA, et al. Echocardiography in the management of patients with left ventricular assist devices: recommendations from the american society of echocardiography. J Am Soc Echocardiogr. 2015;28(8):853‐909. [DOI] [PubMed] [Google Scholar]
  • 8. Mohamed I, Lau CT, Bolen MA, et al. Building a bridge to save a failing ventricle: radiologic evaluation of short‐ and long‐term cardiac assist devices. Radiographics. 2015;35(2):327‐356. [DOI] [PubMed] [Google Scholar]
  • 9. Vogler N, Meyer M, Henzler T. Technical innovations and concepts in coronary CT. In: Nikolaou, K , Bamberg, F , Laghi, A , Rubin, GD eds. Multislice CT. Medical Radiology(). Springer, Cham; 2016:713‐727. [Google Scholar]
  • 10. Guo S, Liu X, Zhang H, et al. Causal knowledge fusion for 3D cross‐modality cardiac image segmentation. Inf Fusion. 2023;99:101864. [Google Scholar]
  • 11. Agdamag AC, Velangi PS, Salavati A, Nijjar PS. CT Imaging of left ventricular assist devices and associated complications. Curr Cardiovasc Imaging Rep. 2020;13(9). [Google Scholar]
  • 12. Tran BC, Nijjar PS. Role of contrast CT for the diagnosis and the prognosis of suspected LVAD thrombosis. J Card Surg. 2017;32(2):162‐165. [DOI] [PubMed] [Google Scholar]
  • 13. Rajendran K, Petersilka M, Henning A, et al. First clinical photon‐counting detector CT system: technical evaluation. Radiology. 2022;303(1):130‐138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Patel AM, Adeseun GA, Ahmed I, Mitter N, Eduardo Rame J, Rudnick MR. Renal failure in patients with left ventricular assist devices. Clinic J Amer Soc Nephrol. 2013;8(3):484‐496. [DOI] [PubMed] [Google Scholar]
  • 15. Sandfort V, Persson M, Pourmorteza A, Noël PB, Fleischmann D, Willemink MJ. Spectral photon‐counting CT in cardiovascular imaging. J Cardiovasc Comput Tomogr. 2021;15(3):218‐225. [DOI] [PubMed] [Google Scholar]
  • 16. Higashigaito K, Mergen V, Eberhard M, et al. CT angiography of the aorta using photon‐counting detector CT with reduced contrast media volume. Radiol Cardiothorac Imaging. 2023;5(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Zhou W, Bartlett DJ, Diehn FE, et al. Reduction of metal artifacts and improvement in dose efficiency using photon‐counting detector computed tomography and tin filtration. Invest Radiol. 2019;54(4):204‐211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Hsieh SS, Leng S, Rajendran K, Tao S, McCollough CH. Photon counting CT: clinical applications and future developments. IEEE Trans Radiat Plasma Med Sci. 2021;5(4):441‐452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Zsarnóczay E, Varga‐Szemes A, Emrich T, et al. Characterizing the heart and the myocardium with photon‐counting CT. Invest Radiol. 2023;58(7):505‐514. [DOI] [PubMed] [Google Scholar]
  • 20. Aquino GJ, O'Doherty J, Schoepf UJ, et al. Myocardial characterization with extracellular volume mapping with a first‐generation photon‐counting detector CT with MRI reference. Radiology. 2023;307(2):e222030. [DOI] [PubMed] [Google Scholar]
  • 21. Meloni A, Cademartiri F, Positano V, et al. Cardiovascular Applications of Photon‐Counting CT Technology: a Revolutionary New Diagnostic Step. J Cardiovasc Dev Dis. 2023;10(9). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Holmes TW, Yin Z, Stevens GM, et al. Ultra‐high‐resolution spectral silicon‐based photon‐counting detector CT for coronary CT angiography: initial results in a dynamic phantom. J Cardiovasc Comput Tomogr. 2023;17(5):341‐344. [DOI] [PubMed] [Google Scholar]
  • 23. Selles M, van Osch J, Maas M, Boomsma M, Wellenberg R. Advances in metal artifact reduction in CT images: a review of traditional and novel metal artifact reduction techniques. Eur J Radiol. 2024:170. [DOI] [PubMed] [Google Scholar]
  • 24. Pallasch FB, Rau A, Reisert M, et al. Impact of different metal artifact reduction techniques in photon‐counting computed tomography head and neck scans in patients with dental hardware. Eur Radiol. Published online November 16, 2023. doi: 10.1007/s00330-023-10430-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Aissa J, Boos J, Sawicki M, et al. Iterative metal artefact reduction (MAR) in postsurgical chest CT: comparison of three iMAR‐algorithms. Br J Radiol. 2017;90:20160778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Long Z, Bruesewitz MR, DeLone DR, et al. Evaluation of projection‐ and dual‐energy‐based methods for metal artifact reduction in CT using a phantom study. J Appl Clin Med Phys. 2018;19(4):252‐260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Kirklin JK. The 2023 ISHLT guidelines for durable mechanical circulatory support: a must read for all advanced heart failure practitioners. J Heart Lung Transplant. 2023;42(7):847‐848. [DOI] [PubMed] [Google Scholar]
  • 28. Kannojiya V, Das AK, Das PK. Effect of left ventricular assist device on the hemodynamics of a patient‐specific left heart. Med Biol Eng Comput. 2022;60(6):1705‐1721. [DOI] [PubMed] [Google Scholar]
  • 29. Kyoto Kagaku Co. L . Radiology Phantom Catalog. Kyoto Kagaku Co., Ltd; 2021. [Google Scholar]
  • 30. Svalkvist A, Svensson S, Hagberg T, Båth M. Viewdex 3.0 ‐ Recent development of a software application facilitating assessment of image quality and observer performance. Radiat Prot Dosimetry. 2021;195(3‐4):372‐377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Svalkvist A, Svensson S, Håkansson M, Båth M, Månsson LG. Viewdex: a status report. Radiat Prot Dosimetry. 2016;169(1‐4):38‐45. [DOI] [PubMed] [Google Scholar]
  • 32. Håkansson M, Svensson S, Zachrisson S, Svalkvist A, Båth M, Månsson LG. ViewDEX: an efficient and easy‐to‐use software for observer performance studies. Radiat Prot Dosimetry. 2010;139(1‐3):42‐51. [DOI] [PubMed] [Google Scholar]
  • 33. Börjesson S, Håkansson M, Båth M, et al. A software tool for increased efficiency in observer performance studies in radiology. Radiat Prot Dosimetry. 2005;114(1‐3):45‐52. [DOI] [PubMed] [Google Scholar]
  • 34. Kataria B. Visual Grading Evaluation of Reconstruction Methods and Dose Optimisation in Abdominal Computed Tomography. Linköping University Electronic Press; 2019. [Google Scholar]
  • 35. Hokamp NG, Eck B, Siedek F, et al. Quantification of metal artifacts in computed tomography: methodological considerations. Quant Imaging Med Surg. 2020;10(5):1033‐1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155‐163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Bamberg F, Dierks A, Nikolaou K, Reiser MF, Becker CR, Johnson TRC. Metal artifact reduction by dual energy computed tomography using monoenergetic extrapolation. Eur Radiol. 2011;21(7):1424‐1429. [DOI] [PubMed] [Google Scholar]
  • 38. Neuhaus V, Große Hokamp N, Abdullayev N, et al. Metal artifact reduction by dual‐layer computed tomography using virtual monoenergetic images. Eur J Radiol. 2017;93:143‐148. [DOI] [PubMed] [Google Scholar]
  • 39. Mangold S, Gatidis S, Luz O, et al. Single‐source dual‐energy computed tomography use of monoenergetic extrapolation for a reduction of metal artifacts. Invest Radiol. 2014;49(12):788‐793. [DOI] [PubMed] [Google Scholar]
  • 40. Do TD, Sommer CM, Melzig C, et al. A Novel Method for Segmentation‐Based Semiautomatic Quantitative Evaluation of Metal Artifact Reduction Algorithms. Invest Radiol. 2019;54(6):365‐373. [DOI] [PubMed] [Google Scholar]
  • 41. Jagoda P, Schmitz D, Wagenpfeil S, Bücker A, Minko P. Comparison of metal artifact reduction in dual‐ And single‐source CT: a vertebral phantom study. Am J Roentgenol. American Roentgen Ray Society; 2018:1298‐1305. [DOI] [PubMed] [Google Scholar]
  • 42. Celikten B, Jacobs R, de Faria Vasconcelos K, et al. Comparative evaluation of cone beam CT and micro‐CT on blooming artifacts in human teeth filled with bioceramic sealers. Clin Oral Investig. 2019;23(8):3267‐3273. [DOI] [PubMed] [Google Scholar]
  • 43. Sandstedt M, Marsh J, Rajendran K, et al. Improved coronary calcification quantification using photon‐counting‐detector CT: an ex vivo study in cadaveric specimens. Eur Radiol. 2021;31:6621‐6630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Mergen V, Sartoretti T, Klotz E, et al. Extracellular volume quantification with cardiac late enhancement scanning using dual‐source photon‐counting detector CT. Invest Radiol. 2022;57(6):406‐411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Euler A, Higashigaito K, Mergen V, et al. High‐pitch photon‐counting detector computed tomography angiography of the aorta: intraindividual comparison to energy‐integrating detector computed tomography at equal radiation dose. Invest Radiol. 2022;57(2):115‐121. [DOI] [PubMed] [Google Scholar]
  • 46. Skornitzke S, Mergen V, Biederer J, et al. Metal artifact reduction in photon‐counting detector CT. Invest Radiol. 2023. Published online October 9, 2023. [DOI] [PubMed] [Google Scholar]
  • 47. Rajagopal JR, Farhadi F, Richards T, et al. Evaluation of coronary plaques and stents with conventional and photon‐counting ct: benefits of highresolution photon‐counting ct. Radiol Cardiothorac Imaging. 2021;3(5). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Elias Michael A, Schoenbeck D, Becker‐Assmann J, et al. Coronary stent imaging in photon counting computed tomography: optimization of reconstruction kernels in a phantom. Eur J Radiol. 2023:166. [DOI] [PubMed] [Google Scholar]
  • 49. Anhaus JA, Schmidt S, Killermann P, Mahnken A, Hofmann C. Iterative metal artifact reduction on a clinical photon counting system—technical possibilities and reconstruction selection for optimal results dependent on the metal scenario. Phys Med Biol. 2022;67(11). [DOI] [PubMed] [Google Scholar]
  • 50. Peng C, Li B, Liang P, et al. A cross‐domain metal trace restoring network for reducing X‐Ray CT metal artifacts. IEEE Trans Med Imaging. 2020;39(12):3831‐3842. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

ACM2-25-e14386-s001.docx (73.9KB, docx)

Articles from Journal of Applied Clinical Medical Physics are provided here courtesy of Wiley

RESOURCES